Shingo Kunioka

Dr. Shingo Kunioka

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
SKShingo Kunioka
Shingo Kunioka
KFKishu Fujita
Kishu Fujita
SIShizuko Iwasa
Shizuko Iwasa
HMHironori Murakami
Hironori Murakami
HKHiroyuki Kamiya
Hiroyuki Kamiya
HTHiroyuki Tsukui
Hiroyuki Tsukui
A myxoma is one of the most common tumors in cardiac surgery, with most of them originating from the left or right atrial walls and causing embolic complications. An 84-year-old woman was referred to our institution after echocardiography showed an interatrial septum tumor that was presumed to be a thrombus; however, postoperative pathological examination revealed it to be a cardiac myxoma. This atypical myxoma was covered with a solid capsule containing connective tissue and substantial calcifications, which had made it difficult to establish a diagnosis of myxoma.

1 April 2020 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
SKShingo Kunioka
Shingo Kunioka
HKHiroto Kitahara
Hiroto Kitahara
NYNoriyuki Yuasa
Noriyuki Yuasa
MFMiri Fujita
Miri Fujita
NONorifumi Otani
Norifumi Otani
HKHiroyuki Kamiya
Hiroyuki Kamiya

12 September 2022 in The Heart Surgery Forum
Verified
Journal Article
Closed access
PDF file
DTDaisuke Takeyoshi
Daisuke Takeyoshi
TSTomonori Shirasaka
Tomonori Shirasaka
KSKeisuke Shibagaki
Keisuke Shibagaki
RORyo Okubo
Ryo Okubo
SKShingo Kunioka
Shingo Kunioka
HKHiroyuki Kamiya
Hiroyuki Kamiya
Background: No study has examined the association of the calcification of abdominal artery orifices with nonocclusive mesenteric ischemia (NOMI) in dialysis patients undergoing cardiac surgery. Thus, this study aimed to determine whether calcification of abdominal blood vessel orifices in hemodialysis patients may be a risk factor for NOMI and examine the long-term survival of dialysis patients after undergoing cardiac surgery. Methods: From April 2014 to September 2020, 100 dialysis patients underwent cardiac surgery at our hospital. The calcification of the celiac artery (CA) and superior mesenteric artery (SMA) was evaluated by computed tomography, and the degree of orifice stenosis was graded as follows: patent, 0; partial occlusion, 1; and complete occlusion, 2. Results: Eight patients experienced NOMI, and all of them died. SMA calcification scores were not significantly different between the NOMI and non-NOMI groups (1.38±0.52 vs. 1.13±0.69; P = 0.247). However, the average CA orifice calcification score was significantly greater in the NOMI group than in the non-NOMI group (1.63±0.52 vs. 1.15±0.65; P = 0.039), and the SMA+CA orifice calcification scores were significantly different between the groups (3.00±0.76 vs. [non-NOMI] 2.25±1.18; P = 0.028). In all patients, the 30-day and in-hospital mortality rates were 13% and 18%, respectively. All patients were completely followed up with a mean follow-up period of 604±585 days. Kaplan–Meier survival curves showed that patients with SMA and CA calcification tended to have a shorter overall survival than patients without calcification; however, no significant difference was noted. Conclusions: The calcification of CA and/or SMA orifices was associated with postoperative NOMI and poor long-term survival among dialysis patients undergoing cardiac surgery.

1 August 2020 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
NINatsuya Ishikawa
Natsuya Ishikawa
AHAina Hirofuji
Aina Hirofuji
SKShingo Kunioka
Shingo Kunioka
TSTomonori Shirasaka
Tomonori Shirasaka
NWNaohiro Wakabayashi
Naohiro Wakabayashi
HKHiroyuki Kamiya
Hiroyuki Kamiya
Unloading of the left ventricle (LV) is essential for the treatment of LV free-wall rupture (LVFWR), and it is well-known that the LV can be optimally unloaded with the Impella system. However, there has been no report on applying the Impella system for the treatment of LVFWR. Here, we report a patient with FWR after massive myocardial infarction who was successfully treated with non-suture repair via median sternotomy and implantation of Impella CP (Abiomed, Danvers, MA).

5 October 2021 in Journal of Chest Surgery
Verified
Journal Article
Open access
PDF file
TSTomonori Shirasaka
Tomonori Shirasaka
SKShingo Kunioka
Shingo Kunioka
MNMasahiko Narita
Masahiko Narita
RURyohei Ushioda
Ryohei Ushioda
KSKeisuke Shibagaki
Keisuke Shibagaki
HKHiroyuki Kamiya
Hiroyuki Kamiya
Tomonori Shirasaka, M.D., Ph.D., Shingo Kunioka, M.D., Masahiko Narita, M.D., Ryohei Ushioda, M.D., Keisuke Shibagaki, M.D., Yuta Kikuchi, M.D., Naohiro Wakabayashi, M.D., Natsuya Ishikawa, M.D., Hiroyuki Kamiya, M.D., Ph.D.. J Chest Surg 2021;54:383-8. https://doi.org/10.5090/jcs.21.048

21 February 2022 in Cureus
Verified
Journal Article
Open access
SKShingo Kunioka
Shingo Kunioka
TSTomonori Shirasaka
Tomonori Shirasaka
HMHiroyuki Miyamoto
Hiroyuki Miyamoto
KSKeisuke Shibagaki
Keisuke Shibagaki
YKYuta Kikuchi
Yuta Kikuchi
HKHiroyuki Kamiya
Hiroyuki Kamiya
Postcardiotomy cardiogenic shock (PCS) is one of the most critical conditions observed in cardiac surgery. Recently, the early initiation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been recommended for PCS patients to ensure end-organ perfusion, especially in high-volume centers. In this study, we investigated the effectiveness of earlier initiation of VA-ECMO for PCS in low-volume centers. We retrospectively assessed patients admitted in two of our related facilities from April 2014 to March 2019. The patients who underwent VA-ECMO during peri- or post-cardiac surgery (within 48 hours) were included. We divided the patients into two groups according to the timing of VA-ECMO initiation. In the early initiation of VA-ECMO group, the “early ECMO group,” VA-ECMO was initiated when patients needed high-dose inotropic support with high-dose catecholamines, such as epinephrine, without waiting for PCS recovery. In the late initiation of VA-ECMO group, the “late ECMO group,” VA-ECMO was delayed until PCS was not controlled with high-dose catecholamines, with the intent of avoiding severe bleeding complications. A total of 30 patients were included in the analysis (early ECMO group/late ECMO group: 19/11 patients). Thirty-day mortality in the entire cohort was 60% (n=18), and there was no significant difference between the two groups (early ECMO group/late ECMO group: 64%/55%, p=0.712). Thirteen and six patients died without being weaned off in the early ECMO (43%) and late ECMO groups (55%), respectively; there was no significant difference between the two groups (p=0.696). The median duration of ECMO support was five days (IQR: 1.5-6.5). The early initiation of ECMO did not contribute to patients’ 30-day outcomes in low-volume centers. To improve outcomes of ECMO therapy in patients with PCS, centralization of low-volume centers may be required.